PT1051393E - Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos - Google Patents

Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos

Info

Publication number
PT1051393E
PT1051393E PT98904231T PT98904231T PT1051393E PT 1051393 E PT1051393 E PT 1051393E PT 98904231 T PT98904231 T PT 98904231T PT 98904231 T PT98904231 T PT 98904231T PT 1051393 E PT1051393 E PT 1051393E
Authority
PT
Portugal
Prior art keywords
radical
aminoalcan
phosphinics
phosphonics
medications
Prior art date
Application number
PT98904231T
Other languages
English (en)
Portuguese (pt)
Inventor
Philippe Durbin
Berthelon Dr Jean-Jacques
Original Assignee
Merck Sante Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sante Sas filed Critical Merck Sante Sas
Publication of PT1051393E publication Critical patent/PT1051393E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PT98904231T 1998-01-27 1998-01-27 Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos PT1051393E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1998/000147 WO1999037606A1 (fr) 1998-01-27 1998-01-27 Nouveaux derives d'acides aminoalkane sulfoniques, phosphoniques et phosphiniques, leur preparation et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
PT1051393E true PT1051393E (pt) 2004-02-27

Family

ID=9521619

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98904231T PT1051393E (pt) 1998-01-27 1998-01-27 Novos derivados de acidos aminoalcano sulfonico fosfonicos e fosfinicos sua preparacao e sua utilizacao como medicamentos

Country Status (12)

Country Link
US (1) US6265437B1 (enExample)
EP (1) EP1051393B1 (enExample)
JP (1) JP4156795B2 (enExample)
AT (1) ATE251129T1 (enExample)
AU (1) AU762988B2 (enExample)
CA (1) CA2319272C (enExample)
DE (1) DE69818709T2 (enExample)
DK (1) DK1051393T3 (enExample)
ES (1) ES2209110T3 (enExample)
PT (1) PT1051393E (enExample)
SI (1) SI1051393T1 (enExample)
WO (1) WO1999037606A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
AR049199A1 (es) 2004-06-04 2006-07-05 Aventis Pharma Inc Derivados de acido propano-fosfinico sustituido
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SI2089417T1 (sl) * 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
TW200924746A (en) * 2007-09-07 2009-06-16 Xenoport Inc Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
US20090099253A1 (en) * 2007-10-15 2009-04-16 Xenoport, Inc. Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
DE102008048791A1 (de) * 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Also Published As

Publication number Publication date
ATE251129T1 (de) 2003-10-15
SI1051393T1 (en) 2004-02-29
JP4156795B2 (ja) 2008-09-24
ES2209110T3 (es) 2004-06-16
EP1051393B1 (fr) 2003-10-01
DK1051393T3 (da) 2004-02-02
CA2319272A1 (en) 1999-07-29
CA2319272C (en) 2005-11-08
DE69818709D1 (en) 2003-11-06
WO1999037606A1 (fr) 1999-07-29
AU762988B2 (en) 2003-07-10
AU6219098A (en) 1999-08-09
JP2002501040A (ja) 2002-01-15
DE69818709T2 (de) 2004-08-19
EP1051393A1 (fr) 2000-11-15
US6265437B1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
MY131271A (en) Liquid detergents with an aryl boronic acid for inhibition of proteolytic enzyme
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
DK1177176T3 (da) Triarylsyrederivater som PPAR-receptorligander
DK0642528T3 (da) Biologisk aktive forbindelser af phosphotriestertypen
ES8307705A1 (es) Un procedimiento para la preparacion de nuevos complejos de carboxilatos, alcoxilados-anfoteros.
ES518227A0 (es) Procedimiento para preparar nuevos compuestos de cefem.
DK438887D0 (da) Fremgangsmaade til fremstilling af kemiske forbindelser
ATE251129T1 (de) Derivatives of aminoalkane sulphonic, phosphonic and phosphinic acids, their preparation and their use as medicaments
ES483289A1 (es) Un procedimiento para la preparacion de 1,2,3,5, tetrahidro-himidazotienopirimidin-2-onas.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
CA2022187A1 (en) N,n-bis-phosphonomethyl taurine n-oxide and water-soluble salts thereof
SE8205867D0 (sv) Noveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique, leurs sels, leur preparation leur application comme medicaments et les compositions les renfermant
AU2732292A (en) Use of specific counteranions to modify the solubility of tetrazolium salts
TR199900153T2 (xx) H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
DE2965701D1 (en) 1-imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions
KR900016154A (ko) 티오우라실 유도체, 이를 함유하는 약학적 조성물 및 이의 제조방법
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
GB2001975A (en) Vincaminol ester derivatives
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
DE3672253D1 (de) Hexensaeuren.
EP1028721A4 (en) N, N'-BIS (SULFONYL) HYDRAZINES FOR USE AS ANTINEOPLASTIC AGENTS
IT1277339B1 (it) Processo per la produzione di agenti contrastografici iodurati
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
FI971177A0 (fi) Bisyklisiä karboksiamideja 5-HT1A-antagonisteina
ES543798A0 (es) Procedimiento de preparacion de nuevos derivados 4-hidroxi- -a-etil-benzoles